Cannabinoid Formulations for Anxiety and Tourette Syndrome
Cannabinoid formulations anxiety treatment shows measurable reductions in anxiety symptoms across various studies. Evidence for Tourette syndrome suggests some benefit in tic severity and anxiety. Patients and clinicians should consider these findings…
Cannabinoid Clinical Trials: Cannabis in HIV Smoking Care
Cannabinoid clinical trials hiv smoking cessation show promising feasibility and acceptability for people living with HIV. Digital therapeutics tailored to this population offer scalable smoking cessation solutions. These trials highlight the potential…
Clinical Data on Transdermal CBD Gel Safety in Fragile X
Transdermal cannabidiol gel safety is being studied in children and adolescents with Fragile X syndrome. Clinical data from ongoing trials evaluate the tolerability of synthetic CBD delivered through the skin. These results provide insight into the…
Endocannabinoid System & Teen Mental Health: Clinical Insights
The internalising pathway cannabis use highlights how adolescents with anxiety and depression symptoms are more likely to use cannabis frequently. This pathway suggests mental health struggles may drive substance use as a coping mechanism. Early…
Adolescent Cannabis Use & Mental Health Risk: Clinical Evidence
Adolescent cannabis psychotic disorder risk is supported by large population-based studies showing increased psychiatric diagnoses. Cannabis use during adolescence is linked to psychotic, bipolar, depressive, and anxiety disorders. This clinical evidence…
Endocannabinoid System & Psychosis Risk: Clinical Evidence
Clinical evidence highlights the role of the endocannabinoid system psychosis risk in first episode psychosis. Identifying risk factors early can improve treatment outcomes. This research supports coordinated care to reduce legal system involvement.
Exploring Posttraumatic Stress, Insomnia, and Cannabis Use
Posttraumatic stress insomnia cannabis use is a critical area of research linking sleep disturbances to substance use risk after trauma. This study highlights the importance of screening for insomnia in trauma survivors. Addressing sleep issues early may…
Evaluating FABP5 as a Therapeutic Target for Pain Management.
FABP5 pain management is emerging as a promising non-opioid approach to analgesia. Pharmacological inhibition of FABP5 shows analgesic effects in preclinical pain models. This target modulates cannabinoid receptor signaling, offering new insights into…
Cannabidiol & Its Anti-Epileptic Properties: Clinical Trial Findings
This clinical trial investigates cannabidiol anti epileptic properties and its effects on cortical excitability. Results indicate CBD alone does not reduce cortical excitability or sedation. The study highlights CBD's benefits may depend on interactions…
Endocannabinoid System Research: Cannabis in Mental Health Care
This article reviews endocannabinoid system cannabis mental health research focusing on clinical trials and digital interventions. It highlights the potential of cannabis in mental health care supported by recent studies. The research explores scalable…